Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trajan Group HoldingsFRA:Z0M 23 Net Margin % is -0.53% as of Dec. 2025. GuruFocus rates FRA:Z0M with a GF Score™ of 23/100 and a GF Value™ of €0.62 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 818 Medical Devices & Instruments companies, Trajan Group Holdings ranks worse than 54.89% on this metric.
The historical rank and industry rank for Trajan Group Holdings's Net Margin % or its related term are showing as below:
FRA:Z0M'
s Net Margin % Range Over the Past 10 Years
Min: -16.34 Med: 1.16 Max: 2.46
Current: -0.81
FRA:Z0M's Net Margin % is ranked worse than 54.89% of 818
companies
in the Medical Devices & Instruments industry
Industry Median: 2.045
vs FRA:Z0M: -0.81
Trajan Group Holdings (FRA:Z0M) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Trajan Group Holdings Net Margin % Related Terms
Trajan Group Holdings Net Margin % Historical Data
* Premium members only.
The historical data trend for Trajan Group Holdings's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:Z0M vs ISRG, BDX, MDLN: Net Margin % Comparison
For the Medical Instruments & Supplies subindustry, Trajan Group Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trajan Group Holdings Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Trajan Group Holdings's Net Margin % distribution charts can be found below:
* The bar in red indicates where Trajan Group Holdings's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trajan Group Holdings (FRA:Z0M) has a Net Margin % of -0.53% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Trajan Group Holdings and its competitors. According to the industry distribution chart, Trajan Group Holdings ranks #449 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 54.9%.
Is Trajan Group Holdings' Net Margin % too high?
Trajan Group Holdings' current Net Margin % is -0.53%. Based on the distribution chart, Trajan Group Holdings ranks #449 out of 818 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Trajan Group Holdings has a GF Score™ of 23/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Trajan Group Holdings' Net Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Trajan Group Holdings ranks #449 out of 818 companies for Net Margin %. This places Trajan Group Holdings in the lower half of its industry. The industry median Net Margin % is 2.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.05, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Trajan Group Holdings and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trajan Group Holdings's current Net Margin % is -0.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trajan Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, Trajan Group Holdings (FRA:Z0M) is currently considered Possible Value Trap. The stock's GF Value™ is €0.62, compared to a current price of €0.17 — trading 73.1% below its estimated fair value. The current Net Margin % is -0.53%. Trajan Group Holdings' overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Trajan Group Holdings (FRA:Z0M), the current Net Margin % is -0.53% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trajan Group Holdings (FRA:Z0M) Overvalued in 2026?
Based on GuruFocus' analysis, Trajan Group Holdings stock appears to be undervalued.
The current stock price of €0.17 is trading 73.1% below its estimated GF Value™ of €0.62.
GuruFocus considers Trajan Group Holdings to be Possible Value Trap.
Key valuation signals for FRA:Z0M:
Net Margin %: -0.53%
GF Value™: €0.62 vs. price of €0.17 (73.1% below fair value)
No single metric tells the full story. See the FRA:Z0M stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trajan Group Holdings Ltd is a developer and manufacturer of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. Its current portfolio of products comprises products, devices and solutions that are used in the analysis of biological, food, and environmental samples. The Group now reports in three operating segments: Components and Consumables, Capital Equipment and Disruptive Technologies. Key revenue is generated from Components and consumables, which include parts, supplies, components, and consumable products worldwide. The Group operates in Asia (Malaysia, Japan and Australia and New Zealand (ANZ)), USA and Europe, Middle East, Africa, and India (EMEA).
23GF Score
Get the complete analysis for FRA:Z0M
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:Z0M has been successfully added to your 
